Skip to main content
Figure 6 | BMC Nephrology

Figure 6

From: Development of an erythropoietin prescription simulator to improve abilities for the prescription of erythropoietin stimulating agents: Is it feasible?

Figure 6

Epoetin dose reduction, equilibration vs. maintenance in simulation B. Error in determining the maintenance dose estimated by calculating the percentage difference between the mean erythropoietin dose used in the equilibration phase and that used in the maintenance phase (half-life of 24, 48 and 138 h; monthly M and weekly W administration). N = 25.

Back to article page

BMC Nephrology

ISSN: 1471-2369

Contact us